Table 2.
Distribution of inflammatory cell subsets within muscle biopsy specimens of anti-HMGCR myopathy and DM patients.
| CD3 | CD4 | CD8 | CD20 | CD68 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | PV | PM | E | PV | PM | E | PV | PM | E | PV | PM | E | PV | PM | |
| HMGCR | 0.67 | 0.18 | 0 | 0.56 | 0.18 | 0 | 0.5 | 0.06 | 0 | 0.17 | 0 | 0 | 1.72 | 0.47 | 0 |
| DM | 0.57 | 1 | 1.14 | 0.43 | 0.86 | 0.71 | 0.29 | 0.43 | 0.57 | 0.14 | 0.71 | 0.57 | 1 | 0.86 | 1.29 |
The biopsy specimens were divided into endomysial (E), perivascular (PV), and perimysial (PM) areas; individual detailed scoring is described in supplementary table S1 (available online). The mean values for each area are recorded in this table.